Skip to main contentSkip to navigationSkip to search
HNSA (, %) SEK
Hansa Biopharma logotype

Events & Webcasts


BAML Global Healthcare Conference



Danske Bank Life Science event "Platform companies"



SEB KOL Expert call on Gene Therapy with Prof. Thomas Sejersen MD, PhD, KI and Lena Winstedt PhD, Global Gene Therapy Franchise Lead, Hansa Biopharma


Load more

Introduction to Hansa

Søren Tulstrup, President & CEO

Anne Säfström Lanner

Join Hansa

From our headquarters in Lund, Sweden, we reach around the world. Our dedicated team includes experienced and courageous specialists driven by our purpose to develop lifesaving and life altering therapies for patients living with rare immunological diseases.

Since our founding in 2007, we have worked in cross functional and agile teams. We are gender-balanced, representing a vast number of nationalities and see diversity as an enabler for reaching our corporate objectives. The recruitment of highly motivated, experienced and talented team players supports our development towards a fully integrated global biopharmaceutical company.

During 2020 Hansa Biopharma AB certified as A Great Place to Work company, by the independent institute Great Place to Work® , a global authority on workplace culture, employee experience and leadership behaviour. We are immensely proud.